Table 2

B-cell subpopulations and immunoglobulin levels of patients expressing XIAPG466X and CD40LG219R

Patient ID*XIAP mutationCD40LG mutationAge, y% CD19+ (6-19)Numbers of CD19+ (/mm3) (110-280)% CD27+ (/CD19+) (> 10)% IgDIgM (/CD19+) (> 4)Ig, g/L
IgG, 9.2-14.8IgA, 1.42-2.6IgM, 0.88-1.84
II-5 G466X WT 39 99 50 13.4 10.4 1.9 1.2 
II-7 G466X G219R 22 ND ND ND ND 1.5 0.2 0.2 
III-1 G466X G219R 29 82 7.3 1.9 5.89 0.36 0.14 
III-2 G466X G219R 27 133 2.4 5.5 0.4 0.13 
III-6 G466X G219R 12 15 (8-24)§ 304 (110-570)§ 6.8 3.5 14.3 (10.5-14.9)§ 4.08 (1.16-2.28)§ 0.73 (0.88-1.72)§ 
C WT G219R 11 (8-24) 253 (270-860) 10 11.5 (8.3-14.3) 1.74 (1.02-1.94) 0.76 (0.68-1.28) 
Patient ID*XIAP mutationCD40LG mutationAge, y% CD19+ (6-19)Numbers of CD19+ (/mm3) (110-280)% CD27+ (/CD19+) (> 10)% IgDIgM (/CD19+) (> 4)Ig, g/L
IgG, 9.2-14.8IgA, 1.42-2.6IgM, 0.88-1.84
II-5 G466X WT 39 99 50 13.4 10.4 1.9 1.2 
II-7 G466X G219R 22 ND ND ND ND 1.5 0.2 0.2 
III-1 G466X G219R 29 82 7.3 1.9 5.89 0.36 0.14 
III-2 G466X G219R 27 133 2.4 5.5 0.4 0.13 
III-6 G466X G219R 12 15 (8-24)§ 304 (110-570)§ 6.8 3.5 14.3 (10.5-14.9)§ 4.08 (1.16-2.28)§ 0.73 (0.88-1.72)§ 
C WT G219R 11 (8-24) 253 (270-860) 10 11.5 (8.3-14.3) 1.74 (1.02-1.94) 0.76 (0.68-1.28) 

ND indicates not determined; and WT, wild type.

Percentage of the B-cell population was determined by flow cytometric analysis from PBMCs of patients after gating on CD19+ cells.

*

Patient identification: The first number (in Roman numerals) corresponds to the generation and the second (Arabic numerals) to the individual in the family (see the pedigree in Figure 1A). Patient C is an unrelated control individual carrier of the CD40LG219R.

Normal values for adults.

Normal values for up to 1-year old child.

§

Normal values for 12-year-old child.

Normal values for 9-year-old child.

With immunoglobulin substitution.

or Create an Account

Close Modal
Close Modal